Selexipag-d7
Selexipag-d7 is the deuterium labeled Selexipag. Selexipag (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor) [1][2].
Product Specifications
CAS Number
1265295-21-3
UNSPSC
12352005
Target
Isotope-Labeled Compounds; Prostaglandin Receptor
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Others
Field of Research
Cardiovascular Disease; Endocrinology
Purity
98.44
Solubility
10 mM in DMSO|DMSO : ≥ 50mg/mL
Smiles
CS(NC(COCCCCN(C1=CN=C(C2=CC=CC=C2)C(C3=CC=CC=C3)=N1)C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])=O)(=O)=O
Molecular Formula
C26H25D7N4O4S
Molecular Weight
503.66
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Kuwano K, et al. 2-[4-[ (5,6-diphenylpyrazin-2-yl) (isopropyl) amino]butoxy]-N- (methylsulfonyl) acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug. J Pharmacol Exp Ther. 2007 Sep;322 (3) :1181-8.|[3]Mous DS, et al. Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag's active compound, at the pseudoglandular stage improves lung vasculature. Am J Physiol Lung Cell Mol Physiol. 2018 May 10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
IP
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CK-bio-10648-01 48 Tests
Human Breast Cancer Anti Estrogen Resistance 1 (BCAR1) ELISA Kit
Sign In for Pricing
View Details CK-bio-10648-02 96 Tests
Human Breast Cancer Anti Estrogen Resistance 1 (BCAR1) ELISA Kit
Sign In for Pricing
View Details